Research discovery

Find the original research

Live search across PubMed, the U.S. National Library of Medicine's citation database, and ClinicalTrials.gov. We show what each record is and link you to it; we don't summarise findings or rank studies by what they conclude.

Published studies · PubMed Clinical trials · ClinicalTrials.gov

Find the original research

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD (opens ClinicalTrials.gov)

Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions (opens ClinicalTrials.gov)

The Long COVID Treatment Trial (opens ClinicalTrials.gov)

Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity (opens ClinicalTrials.gov)

Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB) (opens ClinicalTrials.gov)

Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure (opens ClinicalTrials.gov)

Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity (opens ClinicalTrials.gov)

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (opens ClinicalTrials.gov)

Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy (opens ClinicalTrials.gov)

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities (opens ClinicalTrials.gov)

Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity (opens ClinicalTrials.gov)

Tailored Exercise Training Study Among Adults With HFpEF (opens ClinicalTrials.gov)

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO) (opens ClinicalTrials.gov)

A Study of LY3841136 in Overweight and Obese Participants (opens ClinicalTrials.gov)

Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk (opens ClinicalTrials.gov)

Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data (opens ClinicalTrials.gov)

Tirzepatide for Alcohol Use Disorder (opens ClinicalTrials.gov)

A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants (opens ClinicalTrials.gov)

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (opens ClinicalTrials.gov)

A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes (opens ClinicalTrials.gov)